Intuitive Ebit vs Research Development Analysis

ISRG Stock

USD 484.40 4.67 0.95%

Intuitive Surgical financial indicator trend analysis is infinitely more than just investigating Intuitive Surgical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intuitive Surgical is a good investment. Please check the relationship between Intuitive Surgical Ebit and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.

Ebit vs Research Development

Ebit vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intuitive Surgical Ebit account and Research Development. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Intuitive Surgical's Ebit and Research Development is 0.83. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Research Development in the same time period over historical financial statements of Intuitive Surgical, assuming nothing else is changed. The correlation between historical values of Intuitive Surgical's Ebit and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Intuitive Surgical are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Ebit i.e., Intuitive Surgical's Ebit and Research Development go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Ebit

Research Development

Most indicators from Intuitive Surgical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intuitive Surgical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.The Intuitive Surgical's current Selling General Administrative is estimated to increase to about 2.1 B. The Intuitive Surgical's current Tax Provision is estimated to increase to about 162.9 M

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	310.2M	380.4M	435.2M	457.0M
Income Tax Expense	162.2M	262.4M	141.6M	137.0M

Depreciation And Amortization Income Tax Expense

Intuitive Surgical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Net Debt	Retained Earnings	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Current Assets	Short Term Debt	Common Stock	Non Currrent Assets Other	Common Stock Total Equity	Property Plant And Equipment Gross
Total Assets		0.67	1.0	-0.01	0.96	0.43	0.79	0.99	0.98	0.95	0.96	0.95	0.25	-0.05	0.91	0.71	0.96	0.9	0.95	0.84	0.94	-0.07	0.91	0.07	0.9	0.92
Short Long Term Debt Total	0.67		0.67	-0.36	0.58	0.93	0.58	0.7	0.66	0.58	0.67	0.54	0.13	0.33	0.54	0.58	0.68	0.58	0.56	0.54	0.68	0.05	0.49	-0.2	0.45	0.52
Total Stockholder Equity	1.0	0.67		-0.01	0.96	0.43	0.77	0.98	0.98	0.95	0.95	0.94	0.24	-0.05	0.91	0.71	0.95	0.9	0.94	0.85	0.94	-0.08	0.91	0.06	0.9	0.92
Net Debt	-0.01	-0.36	-0.01		0.14	-0.42	-0.27	-0.1	-0.03	0.08	-0.03	0.07	0.22	-0.99	0.09	-0.09	-0.13	-0.04	0.06	0.02	-0.09	-0.1	0.13	0.12	0.15	0.09
Retained Earnings	0.96	0.58	0.96	0.14		0.35	0.63	0.9	0.9	0.9	0.86	0.92	0.2	-0.2	0.89	0.66	0.89	0.84	0.9	0.8	0.87	-0.21	0.9	0.09	0.89	0.91
Common Stock Shares Outstanding	0.43	0.93	0.43	-0.42	0.35		0.35	0.47	0.43	0.34	0.46	0.25	0.17	0.43	0.25	0.54	0.42	0.44	0.28	0.43	0.52	0.18	0.19	-0.38	0.15	0.21
Non Current Liabilities Total	0.79	0.58	0.77	-0.27	0.63	0.35		0.84	0.86	0.79	0.84	0.79	0.08	0.22	0.74	0.48	0.87	0.65	0.81	0.55	0.71	-0.01	0.82	0.13	0.81	0.79
Other Stockholder Equity	0.99	0.7	0.98	-0.1	0.9	0.47	0.84		0.99	0.94	0.98	0.92	0.25	0.05	0.88	0.72	0.96	0.9	0.93	0.84	0.94	0.0	0.88	0.04	0.87	0.89
Total Liab	0.98	0.66	0.98	-0.03	0.9	0.43	0.86	0.99		0.94	0.98	0.94	0.31	-0.02	0.89	0.69	0.97	0.88	0.95	0.83	0.92	0.03	0.9	0.08	0.89	0.91
Other Current Liab	0.95	0.58	0.95	0.08	0.9	0.34	0.79	0.94	0.94		0.95	0.88	0.17	-0.11	0.81	0.76	0.88	0.92	0.89	0.86	0.92	-0.18	0.89	0.0	0.88	0.86
Total Current Liabilities	0.96	0.67	0.95	-0.03	0.86	0.46	0.84	0.98	0.98	0.95		0.87	0.35	-0.01	0.8	0.79	0.91	0.91	0.89	0.88	0.96	0.09	0.86	-0.07	0.84	0.83
Property Plant And Equipment Net	0.95	0.54	0.94	0.07	0.92	0.25	0.79	0.92	0.94	0.88	0.87		0.16	-0.15	0.98	0.47	0.97	0.75	0.99	0.67	0.78	-0.16	0.95	0.36	0.94	0.99
Accounts Payable	0.25	0.13	0.24	0.22	0.2	0.17	0.08	0.25	0.31	0.17	0.35	0.16		-0.2	0.11	0.32	0.19	0.23	0.24	0.35	0.33	0.79	0.08	-0.28	0.08	0.1
Cash	-0.05	0.33	-0.05	-0.99	-0.2	0.43	0.22	0.05	-0.02	-0.11	-0.01	-0.15	-0.2		-0.18	0.14	0.05	0.02	-0.14	-0.03	0.07	0.13	-0.19	-0.21	-0.21	-0.17
Non Current Assets Total	0.91	0.54	0.91	0.09	0.89	0.25	0.74	0.88	0.89	0.81	0.8	0.98	0.11	-0.18		0.37	0.95	0.68	0.97	0.59	0.7	-0.23	0.92	0.43	0.91	0.98
Cash And Short Term Investments	0.71	0.58	0.71	-0.09	0.66	0.54	0.48	0.72	0.69	0.76	0.79	0.47	0.32	0.14	0.37		0.54	0.85	0.48	0.87	0.89	0.13	0.52	-0.56	0.5	0.43
Net Receivables	0.96	0.68	0.95	-0.13	0.89	0.42	0.87	0.96	0.97	0.88	0.91	0.97	0.19	0.05	0.95	0.54		0.78	0.97	0.71	0.84	-0.08	0.91	0.24	0.9	0.95
Short Term Investments	0.9	0.58	0.9	-0.04	0.84	0.44	0.65	0.9	0.88	0.92	0.91	0.75	0.23	0.02	0.68	0.85	0.78		0.76	0.96	0.95	-0.04	0.71	-0.13	0.69	0.69
Inventory	0.95	0.56	0.94	0.06	0.9	0.28	0.81	0.93	0.95	0.89	0.89	0.99	0.24	-0.14	0.97	0.48	0.97	0.76		0.69	0.79	-0.1	0.92	0.35	0.92	0.97
Other Current Assets	0.84	0.54	0.85	0.02	0.8	0.43	0.55	0.84	0.83	0.86	0.88	0.67	0.35	-0.03	0.59	0.87	0.71	0.96	0.69		0.94	0.06	0.65	-0.26	0.64	0.61
Total Current Assets	0.94	0.68	0.94	-0.09	0.87	0.52	0.71	0.94	0.92	0.92	0.96	0.78	0.33	0.07	0.7	0.89	0.84	0.95	0.79	0.94		0.07	0.78	-0.25	0.76	0.75
Short Term Debt	-0.07	0.05	-0.08	-0.1	-0.21	0.18	-0.01	0.0	0.03	-0.18	0.09	-0.16	0.79	0.13	-0.23	0.13	-0.08	-0.04	-0.1	0.06	0.07		-0.21	-0.38	-0.22	-0.22
Common Stock	0.91	0.49	0.91	0.13	0.9	0.19	0.82	0.88	0.9	0.89	0.86	0.95	0.08	-0.19	0.92	0.52	0.91	0.71	0.92	0.65	0.78	-0.21		0.2	1.0	0.97
Non Currrent Assets Other	0.07	-0.2	0.06	0.12	0.09	-0.38	0.13	0.04	0.08	0.0	-0.07	0.36	-0.28	-0.21	0.43	-0.56	0.24	-0.13	0.35	-0.26	-0.25	-0.38	0.2		0.21	0.36
Common Stock Total Equity	0.9	0.45	0.9	0.15	0.89	0.15	0.81	0.87	0.89	0.88	0.84	0.94	0.08	-0.21	0.91	0.5	0.9	0.69	0.92	0.64	0.76	-0.22	1.0	0.21		0.97
Property Plant And Equipment Gross	0.92	0.52	0.92	0.09	0.91	0.21	0.79	0.89	0.91	0.86	0.83	0.99	0.1	-0.17	0.98	0.43	0.95	0.69	0.97	0.61	0.75	-0.22	0.97	0.36	0.97

Click cells to compare fundamentals

Intuitive Surgical Account Relationship Matchups

Intuitive Surgical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.7B	11.2B	13.6B	13.0B	15.4B	16.2B
Total Stockholder Equity	8.3B	9.8B	12.0B	11.1B	13.3B	14.0B
Net Debt	(1.1B)	(1.5B)	(1.2B)	(1.5B)	(2.7B)	(2.5B)
Retained Earnings	2.5B	3.3B	4.8B	3.5B	4.7B	5.0B
Common Stock Shares Outstanding	358.5M	360.9M	365.8M	362M	357.4M	333.9M
Liabilities And Stockholders Equity	9.7B	11.2B	13.6B	13.0B	15.4B	16.2B
Non Current Liabilities Total	159.7M	139M	224.1M	439.3M	385.5M	404.8M
Other Stockholder Equity	5.8B	6.5B	7.2B	7.8B	8.6B	9.0B
Total Liab	1.4B	1.4B	1.6B	1.9B	2.0B	2.1B
Other Current Liab	568.9M	923.9M	1.0B	1.3B	998.6M	1.0B
Total Current Liabilities	1.4B	1.4B	1.6B	1.9B	1.7B	1.7B
Property Plant And Equipment Net	1.3B	1.6B	1.9B	2.4B	3.5B	3.7B
Accounts Payable	1.1B	81.6M	121.2M	147M	188.7M	101.8M
Cash	1.2B	1.6B	1.3B	1.6B	2.8B	1.6B
Non Current Assets Total	2.2B	3.1B	3.6B	4.4B	7.6B	7.9B
Cash And Short Term Investments	5.8B	6.9B	8.6B	6.7B	5.2B	2.8B
Net Receivables	645.2M	645.5M	782.7M	942.1M	1.3B	1.3B
Short Term Investments	2.1B	3.5B	2.9B	2.5B	2.5B	2.6B
Inventory	595.5M	601.5M	587.1M	893.2M	1.2B	1.3B
Other Current Assets	200.2M	267.5M	271.1M	164.3M	176.7M	185.5M
Total Current Assets	7.5B	8.1B	10.0B	8.6B	7.9B	8.3B
Accumulated Other Comprehensive Income	12.4M	24.9M	(24.2M)	(162.5M)	(12.2M)	(12.8M)
Short Term Debt	568.9M	21.9M	20.4M	24.2M	25.3M	24.0M
Non Currrent Assets Other	(2.4B)	(986.6M)	(3.5B)	(1.6B)	597.6M	627.5M
Property Plant And Equipment Gross	1.3B	1.6B	2.8B	3.6B	5.1B	5.4B
Intangible Assets	112.1M	77.4M	70.5M	49.8M	636.7M	668.5M
Property Plant Equipment	1.3B	1.6B	1.9B	2.4B	2.7B	2.9B
Current Deferred Revenue	365.2M	382.4M	414M	438.3M	446.1M	468.4M
Other Liab	349.6M	386.6M	414M	369.7M	425.2M	446.4M
Other Assets	680.5M	2.1B	13.6B	1.2B	1.4B	1.1B
Good Will	307.2M	336.7M	343.6M	348.5M	348.7M	214.6M
Net Tangible Assets	7.5B	8.9B	11.6B	10.0B	11.5B	5.9B
Noncontrolling Interest In Consolidated Entity	20.9M	27.6M	50.4M	70.7M	81.3M	85.4M
Retained Earnings Total Equity	2.5B	3.3B	4.8B	3.5B	4.0B	4.2B
Capital Surpluse	5.8B	6.4B	7.2B	7.7B	8.9B	4.6B
Deferred Long Term Liab	51.5M	53.1M	71.8M	72.3M	83.1M	87.3M
Long Term Investments	2.6B	1.8B	4.4B	2.6B	2.1B	2.1B

Currently Active Assets on Macroaxis

GM	General Motors
GM	General Motors
GOOG	Alphabet Inc Class C
S	SentinelOne
V	Visa Class A

Additional Information and Resources on Investing in Intuitive Stock

When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:

How To Invest In Intuitive

Details

Is Intuitive Stock a good investment?

Details

What is Intuitive Surgical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.237

Earnings Share

5.81

Revenue Per Share

21.452

Quarterly Revenue Growth

0.145

Return On Assets

0.0799

The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intuitive Ebit vs Research Development Analysis

Ebit vs Research Development

Ebit vs Research Development Correlation Analysis

Correlation Coefficient

Ebit

Research Development

Intuitive Surgical fundamental ratios Correlations

Intuitive Surgical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Intuitive Surgical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Intuitive Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Common Stock Total Equity	+ 1.0	Common Stock
Other Stockholder Equity	+ 0.99	Total Assets
Total Liab	+ 0.99	Other Stockholder Equity
Inventory	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net

Cash	- 0.99	Net Debt
Non Currrent Assets Other	- 0.56	Cash And Short Term Investments
Common Stock Shares Outstanding	- 0.42	Net Debt
Non Currrent Assets Other	- 0.38	Short Term Debt
Non Currrent Assets Other	- 0.38	Common Stock Shares Outstanding
Net Debt	- 0.36	Short Long Term Debt Total